person · Reporting owner

ORTENZIO ROBERT A

Disclosed activity across 2 companies

Tapewire entity: 18141
SEC CIK: 0000918697

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Concentra Group Holdings Parent, Inc.CON · Entity 4001	Director	August 21, 2026	September 01, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Concentra Group Holdings Parent, Inc.

Report date August 21, 2026 · Filed September 01, 2026 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	4,663,794	Reported balance After 2026-08-21 transaction · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · 2026-08-21 · Disposition to issuer · Disposed 770,000 · Balance 4,663,794 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F3: The total number of securities reported has been updated to correct an administrative error.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio Descendants Trust	882,115	Reported balance After 2026-08-21 transaction · row 2 Amendment: may correct only part of an earlier disclosure. 1 source row Row 2 · 2026-08-21 · Disposition to issuer · Disposed 150,000 · Balance 882,115 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F4: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio	196,286	Reported balance After 2026-08-21 transaction · row 3 Amendment: may correct only part of an earlier disclosure. 1 source row Row 3 · 2026-08-21 · Disposition to issuer · Disposed 30,000 · Balance 196,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F5: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio	196,286	Reported balance After 2026-08-21 transaction · row 4 Amendment: may correct only part of an earlier disclosure. 1 source row Row 4 · 2026-08-21 · Disposition to issuer · Disposed 30,000 · Balance 196,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F6: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio	206,286	Reported balance After 2026-08-21 transaction · row 5 Amendment: may correct only part of an earlier disclosure. 1 source row Row 5 · 2026-08-21 · Disposition to issuer · Disposed 20,000 · Balance 206,286 F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee. F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder. F7: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.
Common StockSEC Table I · non-derivative	IndirectThe Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio	503,455	Reported balance Holding disclosure · report date 2026-08-21 · row 6 Amendment: may correct only part of an earlier disclosure. 1 source row Row 6 · Balance 503,455 F8: These shares were inadvertently omitted from the original Form 4 filing. No change in the Reporting Person's beneficial ownership of these shares has occurred.

Filing footnotes · ownership attribution and instrument terms

F1: The shares were sold to the Issuer pursuant to a Stock Repurchase Agreement, dated August 21, 2026, between the Reporting Person (and certain trusts for the benefit of the Reporting Person's descendants) and the Issuer (the "Stock Repurchase Agreement"). Under the Stock Repurchase Agreement, the Issuer agreed to purchase an aggregate of 1,000,000 shares of common stock at a price of $34.65 per share. The Reporting Person sold 770,000 shares held directly and 230,000 shares held indirectly through trusts of which the Reporting Person is the trustee.

F2: The dispositions reported herein were approved in advance by the Audit Committee of the Issuer's Board of Directors, which consists solely of two or more Non-Employee Directors (as defined in Rule 16b-3), for purposes of exempting the transactions from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(e) thereunder.

F3: The total number of securities reported has been updated to correct an administrative error.

F4: 150,000 shares were sold from The Robert A. Ortenzio Descendants Trust at $34.65 per share for aggregate proceeds of $5,197,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.

F5: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Kevin M. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.

F6: 30,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Bryan A. Ortenzio at $34.65 per share for aggregate proceeds of $1,039,500. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.

F7: 20,000 shares were sold from the Robert A. Ortenzio 2014 Trust FBO Madeline G. Ortenzio at $34.65 per share for aggregate proceeds of $693,000. The Reporting Person is the trustee of this trust and may be deemed to have voting and investment power over the shares held therein.

F8: These shares were inadvertently omitted from the original Form 4 filing. No change in the Reporting Person's beneficial ownership of these shares has occurred.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

SELECT MEDICAL HOLDINGS CORP

Report date June 30, 2026 · Filed July 01, 2026

Section 16 reporting ended · disclosed 2026-07-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2026-06-30 transaction · row 1 1 source row Row 1 · 2026-06-30 · Other · Disposed 7,081,788 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F2: Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio Descendants Trust	Last balance in matching sequence After 2026-06-30 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 2 · 2026-06-30 · Other · Disposed 1,000,000 · Balance 279,000 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F3: Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Row 3 · 2026-06-30 · Disposition to issuer · Disposed 279,000 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F5: At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio	Reported balance After 2026-06-30 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F6: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio	Reported balance After 2026-06-30 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 5 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F7: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio	Reported balance After 2026-06-30 transaction · row 6 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 6 · 2026-06-30 · Other · Disposed 280,415 · Balance 0 F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). F8: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP. F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).

F2: Immediately prior to the effective time of the merger, the Reporting Person contributed 6,674,010 common shares and 407,778 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

F3: Immediately prior to the effective time of the merger, The Robert A. Ortenzio Descendants Trust contributed 1,000,000 common shares ("Rollover Shares") to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

F4: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F5: At the effective time of the merger, each of the shares of common stock reported in this row of this Form 4 issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest.

F6: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

F7: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

F8: Immediately prior to the effective time of the merger, The Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio contributed 280,415 common shares to Parent in exchange for an equivalent amount of Parent Common Shares, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
July 30, 2019 Filed Aug 1, 2019 22:50 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	GrantCommon Stock	250,000	$0.00	$0.00	Disclosure SEC source: 0001179110-19-008979 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,439,823 F1 · kind: Grant of shares of restricted stock to certain Executive Officers of the Issuer, which will vest in full on 07/30/2022. Read SEC document
November 09, 2018 Filed Nov 13, 2018 22:07 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	640	$20.00	$12,800.00	Disclosure SEC source: 0001179110-18-012787 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,189,823 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
November 08, 2018 Filed Nov 9, 2018 00:17 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	25,274	$20.00	$505,480.00	Disclosure SEC source: 0001179110-18-012696 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,190,463 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
November 07, 2018 Filed Nov 9, 2018 00:17 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	35,834	$20.09	$719,905.06	Disclosure SEC source: 0001179110-18-012696 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,215,737 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.20, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
November 06, 2018 Filed Nov 9, 2018 00:17 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	37,468	$20.05	$751,233.40	Disclosure SEC source: 0001179110-18-012696 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,251,571 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.09, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
August 31, 2018 Filed Aug 31, 2018 20:05 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	1,700	$20.00	$34,000.00	Disclosure SEC source: 0001179110-18-011033 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,998,271 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
August 31, 2018 Filed Aug 31, 2018 20:05 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	200	$20.03	$4,006.00	Disclosure SEC source: 0001179110-18-011033 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,999,971 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
August 30, 2018 Filed Aug 31, 2018 20:05 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	11,923	$20.00	$238,460.00	Disclosure SEC source: 0001179110-18-011033 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000,171 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
August 07, 2018 Filed Aug 7, 2018 23:36 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	10,402	$20.16	$209,704.32	Disclosure SEC source: 0001179110-18-010363 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,012,094 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.35, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document
July 31, 2018 Filed Aug 2, 2018 21:12 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	GrantCommon Stock	250,000	$0.00	$0.00	Disclosure SEC source: 0001179110-18-010161 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,022,496 F1 · shares: Grant of restricted stock which, subject to certain exceptions, will vest in full on July 31, 2021, the third anniversary of the grant date. Read SEC document
June 14, 2018 Filed Jun 15, 2018 00:09 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	17,252	$18.53	$319,679.56	Disclosure SEC source: 0001179110-18-008554 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,772,496 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in this column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.60, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document
June 13, 2018 Filed Jun 15, 2018 00:09 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	3,800	$18.50	$70,300.00	Disclosure SEC source: 0001179110-18-008554 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,789,748 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
June 12, 2018 Filed Jun 12, 2018 21:27 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	73,448	$18.66	$1,370,539.68	Disclosure SEC source: 0001179110-18-008404 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,793,548 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F3 · price: The price reported in this column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.95, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document
June 11, 2018 Filed Jun 12, 2018 21:27 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	119,253	$18.63	$2,221,683.39	Disclosure SEC source: 0001179110-18-008404 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,866,996 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in this column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.70, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document
June 08, 2018 Filed Jun 12, 2018 21:27 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	152	$18.50	$2,812.00	Disclosure SEC source: 0001179110-18-008404 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,986,249 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
June 06, 2018 Filed Jun 7, 2018 21:57 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	200	$18.50	$3,700.00	Disclosure SEC source: 0001179110-18-008234 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,986,401 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
June 05, 2018 Filed Jun 7, 2018 21:57 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	2,990	$18.50	$55,315.00	Disclosure SEC source: 0001179110-18-008234 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,986,601 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. Read SEC document
May 30, 2018 Filed Jun 1, 2018 21:13 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	34,416	$18.51	$637,040.16	Disclosure SEC source: 0001179110-18-007836 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,989,591 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.60, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document
May 23, 2018 Filed May 23, 2018 21:20 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	2,920	$18.52	$54,078.40	Disclosure SEC source: 0001179110-18-007430 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,024,007 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.55, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
May 22, 2018 Filed May 23, 2018 21:20 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	59,553	$18.53	$1,103,517.09	Disclosure SEC source: 0001179110-18-007430 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,026,927 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.63, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
May 21, 2018 Filed May 23, 2018 21:20 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	85,740	$18.57	$1,592,191.80	Disclosure SEC source: 0001179110-18-007430 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,086,480 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.70, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
May 18, 2018 Filed May 18, 2018 21:09 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	20,742	$18.52	$384,141.84	Disclosure SEC source: 0001179110-18-007127 · edgar.xml · nonDerivative · entry 3 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,172,220 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.60, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
May 17, 2018 Filed May 18, 2018 21:09 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	32,923	$18.56	$611,050.88	Disclosure SEC source: 0001179110-18-007127 · edgar.xml · nonDerivative · entry 2 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,192,962 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.70, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
May 16, 2018 Filed May 18, 2018 21:09 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	SaleCommon Stock	46,611	$18.52	$863,235.72	Disclosure SEC source: 0001179110-18-007127 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,225,885 F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on November 14, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.50 to $18.60, inclusive. The reporting person undertakes to provide to Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document
August 02, 2017 Filed Aug 4, 2017 20:57 UTC	SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845	GrantCommon Stock	250,000	$0.00	$0.00	Disclosure SEC source: 0001179110-17-011149 · edgar.xml · nonDerivative · entry 1 ORTENZIO ROBERT A · CIK 0000918697 · Director · Exec. Chairman and Co-Founder 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,272,496 F1 · shares: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 2, 2020, the third anniversary of the grant date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.